NSEGeneral Updates30 Jun 2026 · 30 Jun 2026, 06:41 pm

General Updates

Jubilant Pharmova Limited · JUBLPHARMA

✦ AI SummaryLitigation

Jubilant Pharmova Limited has received a rectification order from the jurisdictional Assessing Officer in Noida for Assessment Year 2019-20, disallowing a claim of forward losses of Rs. 53.37 crores. The company is in the process of filing an appeal before the Appellate Authority (National Faceless Appeal Centre) against the impugned order.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Pharmova Limited has informed the Exchange about General Updates

Attachments (1)

📄

JUBLPHARMA_30062026184057_JBL_-_Stock_Exchange_Disclosure.pdf

pdf

Download →
View document text
June 30, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex Mumbai - 400 001 Bandra (E) Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir, Pursuant to Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, we hereby inform that Jubilant Biosys Limited (wholly owned subsidiary of Jubilant Pharmova Ltd.) has received a rectification order dated June 29, 2026 from the jurisdictional Assessing Officer in Noida for Assessment Year 2019-20 (Financial Year 2018-19). The information in the relevant format is enclosed as Annexure A. The Company believes that the impugned tax adjustment has been made ignoring the facts and contentions of the Company and provisions of law. The Company is in the process of taking the necessary action to file an appeal before the Appellate Authority [National Faceless Appeal Centre (NFAC)] against the impugned order. Post adjudication by Appellate authority, impugned adjustment is likely to get deleted. Date and time of occurrence of event is June 30, 2026, 12:20 pm (IST). The above-mentioned document is being simultaneously posted on the Company's website at www.jubilantpharmova.com. We request you to take this on record. Thanking you. Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Annexure A Sr. Brief details of Name of the Court/tribunal/ Expected financial Quantum of No. Litigation opposing party Agency where implications, if any, claims (in Rs. litigation is due to compensation, crores) filed penalty etc. 1 Rectification order DCIT, Noida Company is in Company is in the Disallowance dated June 29, 2026 the process of process of filing an of claim of amending assessment filing an appeal appeal before first brought u/s 143(1) of the before National level Appellate forward losses Income-tax Act, Faceless Appeal Authority (National of Rs. 53.37 1961, passed by the Centre (NFAC) Faceless Appeal crores jurisdictional Centre - NFAC) Assessing Officer in against the Noida for Assessment rectification order and Year 2019-20 expects to get relief (Financial Year 2018- from the Appellate 19) disallowing the Authority and does not claim of brought anticipate any material forward losses of Rs. adverse financial 53.37 crores implication